Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Rogers

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Mental Health in Family Medicine|April 6, 2012
Rates of depression among men attending high-HIV-caseload general practices in AustraliaLimin Mao, Susan C Kippax, Christy E Newman, et al.
PDA Journal of Pharmaceutical Science and Technology|October 3, 2015
Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology ProductsKim Li, Gary Rogers, Yasser Nashed-Samuel, et al.
Experimental Neurology|March 1, 2002
Survival signaling and selective neuroprotection through glutamatergic transmissionBen A Bahr, Jennifer Bendiske, Queenie B Brown, et al.
Australian and New Zealand Journal of Public Health|February 25, 2009
Social factors associated with Major Depressive Disorder in homosexually active, gay men attending general practices in urban AustraliaLimin Mao, Michael R Kidd, Gary Rogers, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Benzoxazinones as potent positive allosteric AMPA receptor modulators: part IRudolf Mueller, Yong-Xin Li, Aidan Hampson, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Substituted benzoxazinones as potent positive allosteric AMPA receptor modulators: part IIRudolf Mueller, Stanislaw Rachwal, Martina E Tedder, et al.
PDA Journal of Pharmaceutical Science and Technology|April 10, 2013
Identification of a leachable compound detrimental to cell growth in single-use bioprocess containersMatthew Hammond, Heather Nunn, Gary Rogers, et al.
Lancet (London, England)|February 14, 2004
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trialAndrew Carr, Cassy Workman, Dianne Carey, et al.
Plos Genetics|January 7, 2014
DNA methylation changes separate allergic patients from healthy controls and may reflect altered CD4+ T-cell population structureColm E Nestor, Fredrik Barrenäs, Hui Wang, et al.
PDA Journal of Pharmaceutical Science and Technology|February 19, 2015
Extractables analysis of single-use flexible plastic biocontainersLiliana Marghitoiu, Jian Liu, Hans Lee, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Mental Health in Family Medicine|April 6, 2012
Rates of depression among men attending high-HIV-caseload general practices in AustraliaLimin Mao, Susan C Kippax, Christy E Newman, et al.
PDA Journal of Pharmaceutical Science and Technology|October 3, 2015
Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology ProductsKim Li, Gary Rogers, Yasser Nashed-Samuel, et al.
Experimental Neurology|March 1, 2002
Survival signaling and selective neuroprotection through glutamatergic transmissionBen A Bahr, Jennifer Bendiske, Queenie B Brown, et al.
Australian and New Zealand Journal of Public Health|February 25, 2009
Social factors associated with Major Depressive Disorder in homosexually active, gay men attending general practices in urban AustraliaLimin Mao, Michael R Kidd, Gary Rogers, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Benzoxazinones as potent positive allosteric AMPA receptor modulators: part IRudolf Mueller, Yong-Xin Li, Aidan Hampson, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Substituted benzoxazinones as potent positive allosteric AMPA receptor modulators: part IIRudolf Mueller, Stanislaw Rachwal, Martina E Tedder, et al.
PDA Journal of Pharmaceutical Science and Technology|April 10, 2013
Identification of a leachable compound detrimental to cell growth in single-use bioprocess containersMatthew Hammond, Heather Nunn, Gary Rogers, et al.
Lancet (London, England)|February 14, 2004
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trialAndrew Carr, Cassy Workman, Dianne Carey, et al.
Plos Genetics|January 7, 2014
DNA methylation changes separate allergic patients from healthy controls and may reflect altered CD4+ T-cell population structureColm E Nestor, Fredrik Barrenäs, Hui Wang, et al.
PDA Journal of Pharmaceutical Science and Technology|February 19, 2015
Extractables analysis of single-use flexible plastic biocontainersLiliana Marghitoiu, Jian Liu, Hans Lee, et al.
Pageof 5